Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7737695

Concept	2016-04-01 to 2017-03-31	As at 2017-03-31	As at 2017-03-31	2016-04-01 to 2017-03-31	As at 2016-03-31	As at 2016-03-31	2015-04-01 to 2016-03-31	2015-04-01 to 2016-03-31	2014-04-01 to 2015-03-31	2014-04-01 to 2015-03-31	As at 2015-03-31	As at 2015-03-31	2013-04-01 to 2014-03-31	As at 2014-03-31	2013-04-01 to 2014-03-31	As at 2014-03-31	2012-04-01 to 2013-03-31	As at 2013-03-31	As at 2013-03-31	2012-04-01 to 2013-03-31
Key financial data of reporting company
Business results of reporting company
Net sales	529,612,000 JPY	—	—	529,612,000 JPY	—	—	822,556,000 JPY	JPY	821,625,000 JPY	JPY	—	—	933,388,000 JPY	—	JPY	—	JPY	—	—	451,495,000 JPY
Ordinary profit (loss)	-1,089,724,000 JPY	—	—	-1,116,556,000 JPY	—	—	-992,977,000 JPY	JPY	-413,501,000 JPY	JPY	—	—	19,144,000 JPY	—	JPY	—	JPY	—	—	219,537,000 JPY
Profit (loss)	-1,113,661,000 JPY	—	—	—	—	—	-994,464,000 JPY	—	-412,435,000 JPY	—	—	—	17,485,000 JPY	—	—	—	—	—	—	217,610,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied	JPY	—	—	—	—	—	JPY	—	JPY	—	—	—	JPY	—	—	—	—	—	—	JPY
Share capital	—	—	3,774,413,000 JPY	—	—	1,988,085,000 JPY	—	—	—	—	642,585,000 JPY	—	—	—	—	16,415,000 JPY	—	16,415,000 JPY	—	—
Total number of issued shares	—	—	37,218,400 xbrli:shares	—	—	31,807,700 xbrli:shares	—	—	—	—	210,649 xbrli:shares	—	—	—	—	97,015 xbrli:shares	—	97,015 xbrli:shares	—	—
Net assets	—	5,201,149,000 JPY	5,199,874,000 JPY	—	JPY	2,720,663,000 JPY	—	—	—	—	1,024,127,000 JPY	JPY	—	JPY	—	189,323,000 JPY	—	172,462,000 JPY	JPY	—
Total assets	—	5,408,300,000 JPY	5,404,266,000 JPY	—	JPY	2,877,251,000 JPY	—	—	—	—	1,227,465,000 JPY	JPY	—	JPY	—	396,510,000 JPY	—	212,420,000 JPY	JPY	—
Net assets per share	—	139.17	139.17	—		85.53	—	—	—	—	30.74		—		—	4.53	—	3.78		—
Dividend paid per share		—	—	—	—	—		—		—	—	—		—	—	—	—	—	—
Interim dividend paid per share		—	—	—	—	—		—		—	—	—		—	—	—	—	—	—
Basic earnings (loss) per share	-32.74	—	—	-32.74	—	—	-35.28		-20.60		—	—	1.46	—		—		—	—	18.22
Diluted earnings per share		—	—		—	—					—	—		—		—		—	—
Equity-to-asset ratio	—	0.958 xbrli:pure	0.958 xbrli:pure	—	xbrli:pure	0.946 xbrli:pure	—	—	—	—	0.834 xbrli:pure	xbrli:pure	—	xbrli:pure	—	0.465 xbrli:pure	—	0.785 xbrli:pure	xbrli:pure	—
Rate of return on equity	xbrli:pure	—	—	xbrli:pure	—	—	xbrli:pure	xbrli:pure	xbrli:pure	xbrli:pure	—	—	0.100 xbrli:pure	—	xbrli:pure	—	xbrli:pure	—	—	3.756 xbrli:pure
Price-earnings ratio	xbrli:pure	—	—	xbrli:pure	—	—	xbrli:pure	xbrli:pure	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—	—	xbrli:pure
Payout ratio	xbrli:pure	—	—	—	—	—	xbrli:pure	—	xbrli:pure	—	—	—	xbrli:pure	—	—	—	—	—	—	xbrli:pure
Net cash provided by (used in) operating activities	JPY	—	—	-1,067,512,000 JPY	—	—	-908,711,000 JPY	JPY	-447,197,000 JPY	JPY	—	—	37,487,000 JPY	—	JPY	—	JPY	—	—	JPY
Net cash provided by (used in) investing activities	JPY	—	—	-96,564,000 JPY	—	—	-32,125,000 JPY	JPY	-66,854,000 JPY	JPY	—	—	-3,688,000 JPY	—	JPY	—	JPY	—	—	JPY
Net cash provided by (used in) financing activities	JPY	—	—	3,559,188,000 JPY	—	—	2,672,558,000 JPY	JPY	1,247,716,000 JPY	JPY	—	—	JPY	—	JPY	—	JPY	—	—	JPY
Cash and cash equivalents	—	4,950,570,000 JPY	JPY	—	JPY	2,555,458,000 JPY	—	—	—	—	823,737,000 JPY	JPY	—	JPY	—	90,073,000 JPY	—	JPY	JPY	—
Number of employees	—	37 xbrli:pure	37 xbrli:pure	—	xbrli:pure	21 xbrli:pure	—	—	—	—	19 xbrli:pure	xbrli:pure	—	xbrli:pure	—	16 xbrli:pure	—	11 xbrli:pure	xbrli:pure	—
Average number of temporary employees	—	4 xbrli:pure	4 xbrli:pure	—	xbrli:pure	5 xbrli:pure	—	—	—	—	4 xbrli:pure	xbrli:pure	—	xbrli:pure	—	1 xbrli:pure	—	3 xbrli:pure	xbrli:pure	—